Canada has reversed its earlier position on Leqembi (lecanemab), with Canada's Drug Agency now recommending public reimbursement for people with early Alzheimer's disease. #Alzheimers #Leqembi #MedicalNews

The recommendation reverses the agency's February 2026 decision ...against public coverage. More than 770,000 people in Canada are currently living with dementia, with that number projected to reach about 1.7 million by 2050. #AlzheimersDisease #Dementia #HealthcareNews

The recommendation still needs to move through pricing negotiations and individual provincial coverage decisions before patients can access publicly funded treatment. #DrugNews #Healthcare #Canada

🚨 The UK medicines regulator has suspended avacopan for new patients after concerns emerged over the integrity of data from the pivotal clinical trial used to support its approval. #MHRA #DrugSafety #MedicalNews

The drug is used to treat ANCA-associated vasculitis, rare autoimmune ...diseases that can damage small blood vessels and organs. Existing patients can continue treatment during a managed six-month withdrawal, while the UK authorization is scheduled to be revoked in March 2027. #AutoimmuneDisease #DrugNews #HealthcareNews

The decision follows the retraction of the ADVOCATE trial at the request of two academic authors and comes after the European authorization was revoked in August. #ClinicalTrials #PharmaNews #FDA

The WHO has issued updated emergency guidance on the possible use of Ervebo during the ongoing Ebola outbreak involving the Bundibugyo virus. The guidance, released September 1, addresses how an existing Ebola vaccine could potentially be used even though it was developed for a different Ebola ...species. #WHO #Ebola #VaccineNews

Ervebo is licensed for protection against Zaire ebolavirus, while the current outbreak involves Bundibugyo ebolavirus. The updated guidance focuses on how vaccination could fit into an emergency response where no licensed vaccine specifically targets the circulating strain. #EbolaOutbreak #GlobalHealth #PublicHealth

🚨 The Democratic Republic of Congo is facing the second-largest Ebola outbreak ever recorded, with 6,342 confirmed cases and 3,072 deaths reported as of September 3. The outbreak is being driven by the rare Bundibugyo strain, which currently has no approved vaccine or treatment specifically ...targeting that strain.

The outbreak has spread across multiple provinces, including #Ituri and #NorthKivu, while health agencies continue working to contain transmission. The WHO says the epidemic is moving faster than any previous Ebola outbreak. #Ebola #EbolaOutbreak #GlobalHealth

More than 1,700 Doctors Without Borders staff are reportedly involved in the response. #PublicHealth #MedicalNews #HealthNews

The FDA has issued an Emergency Use Authorization for drugs to prevent and treat New World screwworm infestations in dogs and cats as the parasite continues spreading north. #FDA #AnimalHealth #PetHealth

New World screwworm is a parasitic fly whose larvae can infest the tissue of animals, ...creating a serious threat to animal health. The FDA announced the emergency authorization on September 3, 2026, as officials respond to the growing concern. #Screwworm #VeterinaryMedicine #MedicalNews